Aphria CEO Optimistic About Future of Cannabis Despite Covid

The transcript discusses Aphria's financial performance, highlighting a 130% business growth and a focus on recreational cannabis. The company has a strong facility and workforce, maintaining operations during COVID-19. Despite stock volatility, Aphria has achieved five quarters of profitability and is a leading cannabis company in Canada. The potential merger with Aurora was explored but not realized. Future opportunities include expanding into the US market and cannabis 2.0 products. Aphria emphasizes cost efficiency and aims to capture market share from the illicit market.

What was the percentage growth of Aphria's business over the year?

• 150%

• 2%

• 27%

• 130%

Which market did Aphria focus on for growth?

• Recreational cannabis

• Latin America

• Medical cannabis

• Bulk sales

How did Aphria's stock perform over the last four or five months?

• Decreased by 17%

• Remained stable

• Increased by 17%

• Decreased by 27%

What is a significant opportunity for Aphria in the cannabis industry?

• Reducing the number of stores

• Focusing solely on medical cannabis

• Expanding into the illicit market

• Merging with Aurora

What is the cost of producing cannabis per gram for Aphria?

• $1.00

• $0.50

• $1.50

• $0.88

What is the size comparison between the illicit and legalized cannabis markets?

• Illicit market is smaller

• Illicit market is three times larger

• Both are the same size

• Legalized market is three times larger

What is Aphria's strategy for future growth?

• Focusing only on the Canadian market

• Laying off employees

• Merging with other companies

• Strategic use of cash and efficiency improvements